Find your path to Shannon
431 people in our graph share verified history with Shannon — schools, employers, funds. One of them is your warm intro.
Wesley ChanunlockedShannon: together at Massachusetts Institute of Technology (1996–1999)
×10Shannon: together at Massachusetts Institute of Technology
Shannon: together at Harvard Medical School
About
Shannon Dahl is the Founder and Chief Executive Officer of Carve Bio and has held roles as Chief Scientific Officer and board director in the biotechnology sector. Dahl's experience spans R&D strategy, clinical translation, commercialization, payer relationships and reimbursement, and biomanufacturing and GMP processes, covering stages from early-stage research through Phase 3 clinical trials. Additional areas of work include strategic partnerships, fundraising, and advising biotech startups as a board member.
Chief Scientific Officer at Iolyx
Intro paths
→
In turn, Shannon can intro founders to Iolyx's investors below.
Iolyx's investors · 1
Experience
- Carve BioFounder and Chief Executive Officer (CEO)current2021 — present
- Iolyx TherapeuticsChief Scientific Officercurrent2022 — present
- California Institute for Regenerative Medicine (CIRM)Board of Directorscurrent2025 — present
- Digitalis CommonsExpert-in-Residence (XIR)current2024 — present
- Radar TherapeuticsStrategic Advisor to CEOcurrent2023 — present
- Laguna BioStrategic Advisor to CEOcurrent2024 — present
- Laguna BioChief Scientific Officer2023 — 2024
- Strand TherapeuticsStrategic Advisory Boardcurrent2019 — present
- InvectysStrategic Advisor to Chair of the Board of Directors2025
- HepaTx CorporationScientific Advisory Board2017 — 2024
- Epic BioChief Business Advisor2023
- 4:59 NewCo, a 5AM Ventures CompanyInterim Chief Scientific Officer2021 — 2022
- Cell Care TherapeuticsChief Scientific Officer2018 — 2021
- HumacyteCo-Founder, Leader of Reimbursement Strategy2014 — 2018
- HumacyteCo-Founder, VP Technology and Pipeline Development2012 — 2014
- HumacyteCo-Founder, Senior Director of Scientific Operations | Principal Scientist2004 — 2012
- Duke UniversityAdjunct Faculty, Department of Surgery2013 — 2018
- Harvard Medical SchoolResearch in Orthopedic Surgery1998 — 1999
Skills & more
Leadership3Commercial StrategyStrategic PlanningCommunicationBiotechnology22R&DStrategic Partnerships7FDA8Translational MedicineBusiness GrowthOrganizational Leadership6U.S. Food and Drug Administration (FDA)3
+12 more
Research and Development (R&D)Product DevelopmentCross-functional Team LeadershipPatent Portfolio DevelopmentInfluenceExecutive LeadershipBusiness DevelopmentLeadership DevelopmentGovernment AdvocacyPatient AdvocacyMedical ResearchCMC Regulatory AffairsFrom Shannon's professional profile.
Frequently asked questions
- Who is Shannon Dahl?
- Shannon Dahl is the Founder and Chief Executive Officer of Carve Bio and has held roles as Chief Scientific Officer and board director in the biotechnology sector. Dahl's experience spans R&D strategy, clinical translation, commercialization, payer relationships and reimbursement, and biomanufacturing and GMP processes, covering stages from early-stage research through Phase 3 clinical trials. Additional areas of work include strategic partnerships, fundraising, and advising biotech startups as a board member.
- Where does Shannon Dahl work?
- Shannon Dahl is Chief Scientific Officer at Iolyx.
- Where did Shannon Dahl go to school?
- Shannon Dahl studied at Massachusetts Institute of Technology (S.B., Materials Science and Engineering (Regenerative Medicine & Biomaterials)); Duke University (Ph.D., Biomedical Engineering (Regenerative Medicine)); The George Washington University (Boardroom Ready Corporate Governance for Executive Women in Bio (adapted from Biogen's program)).
Same school
Also attended Massachusetts Institute of Technology2,000
Hemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and TechstarsMatt HuangCo-founder and Managing Partner at ParadigmDelian AsparouhovPartner at Founders Fund and co-founder of VardaDrew HoustonCo-founder & CEO of Dropbox
+ 1,994 more
Also attended Duke University948
Marc AndreessenCo-founder & General Partner at Andreessen HorowitzFred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeJeremy LevinePartner at Bessemer Venture PartnersZach PerretCo-founder & CEO of Plaid; co-founder of MischiefJulie YangVice President at InvestcorpAyaan PatelInvestor at Lightbank
+ 942 more
Also attended The George Washington University382
RustyAdvisor at Clear VenturesDonna HoyleVice President & Controller at RevolutionMathew KayeAccounting Manager at RevolutionMeghan FahyDirector of Marketing at GreycroftMaurice RussoInvestor at Lerer HippeauZach CollinsPartner at Mission Biocapital
+ 376 more
Shared employers
Also worked at Radar Therapeutics4
Also worked at HepaTx Corporation1
Also worked at Humacyte6
Jeff LawsonPhysician-Scientist, Inventor, Entrepreneur, Innovator, and Investor at Swift Street CapitalLaura Niklason, MD, PhDFounder at HumacyteRobin Hyde-DeRuyscherFounder at Emergo TherapeuticsTed LithgowExecutive Officer at HumacytePaul BoyerExecutive Officer at HumacyteDale A SanderExecutive Officer at Avita Medical
Also worked at Harvard Medical School336
Logan HilleLife Sciences Analyst at CincyTechAnkit GuptaGeneral Partner at Y CombinatorDavid MollerInvestor at Third Rock VenturesSamuel ArbesmanVenture Partner at Lux CapitalZach CollinsPartner at Mission BiocapitalAlexi Nazem, MDGeneral Partner at AlleyCorp
+ 330 more